<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04947592</url>
  </required_header>
  <id_info>
    <org_study_id>Hamaky13</org_study_id>
    <nct_id>NCT04947592</nct_id>
  </id_info>
  <brief_title>SD-OCT Guided Treatment of Fungal Chorioretinitis</brief_title>
  <official_title>Outcome of SD-OCT Guided Oral Anti-fungal Treatment of Fungal Chorioretinitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benha University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Benha University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fungal Chorioretinitis is a vision threatening condition.The investigators evaluate the&#xD;
      efficacy of SD-OCT role in the treatment&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Baseline ,and postoperative 1 ,6 and 12 months full ophthalmic examination and SD-OCT was&#xD;
      done.Procedure included oral fluconazole treatment 1 tablet once for 14 days&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 15, 2021</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Best corrected visual acuity (BCVA)</measure>
    <time_frame>6 months</time_frame>
    <description>Change in BCVA in LOG MARS(logarithm minimum angle of resolution</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>optical coherence tomography (OCT) foveal thickness</measure>
    <time_frame>6 months</time_frame>
    <description>change in foveal thickness measured in micrometer</description>
  </secondary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Fungal Retinitis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluconazole 150 mg</intervention_name>
    <description>fluconazole 150 MG once daily for 14 days</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        at least 18 years old patient with fungal chorioretinitis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - fungal chorioretinitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  vitritis&#xD;
&#xD;
          -  other macular lesion&#xD;
&#xD;
          -  macular scar&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>TAREK ELHAMAKY</last_name>
    <role>Principal Investigator</role>
    <affiliation>Benha University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>TAREK R ELHAMAKY, MD</last_name>
    <phone>0503207889</phone>
    <email>thamaky@ibnnafees.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>TAREK ELHAMAKY</last_name>
    <phone>0503207889</phone>
    <email>thamaky@ibnnafees.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>INMC</name>
      <address>
        <city>Abu Dhabi</city>
        <zip>46266</zip>
        <country>United Arab Emirates</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>TAREK R ELHAMAKY, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United Arab Emirates</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 24, 2021</study_first_submitted>
  <study_first_submitted_qc>June 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2021</study_first_posted>
  <last_update_submitted>June 24, 2021</last_update_submitted>
  <last_update_submitted_qc>June 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benha University</investigator_affiliation>
    <investigator_full_name>Tarek Roshdy mohamed Mahgoub ELhamaky</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>fungal</keyword>
  <keyword>chorioretinitis</keyword>
  <keyword>OCT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinitis</mesh_term>
    <mesh_term>Chorioretinitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluconazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

